Proteomics Market Size to Reach $49.97 Bn, Globally, by 2027 at 12.2% CAGR: Allied Market Research

Rise in popularity of personalized medicines, growth in R&D expenditure, and technological advancements related to proteomics components drive the growth of the global proteomics market

News provided by

Allied Market Research

Mar 17, 2021, 09:15 ET

PORTLAND, Ore., March 17, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Proteomics Market by Component (Instruments, Reagents, and Services) and Application (Drug Discovery, Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027." The report offers a comprehensive analysis of top winning strategies, recent developments, market dynamics, key segments, and market players. According to the report, the global Proteomics Market Size garnered $21.12 billion in 2019 and is expected to reach $49.97 billion by 2027, registering a CAGR of 12.2% from 2020 to 2027.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/1677

Key determinants in the market-

Rise in popularity of personalized medicines, growth in R&D expenditure, and technological advancements related to proteomics components drive the growth of the global proteomics market. However, lack of skilled professionals and high costs related to proteomics components restrain the growth. On the other hand, biomarker identification and advancements in mass spectrometry-based proteomics are expected to usher a plethora of opportunities in the near future.

Covid-19 Scenarios-

Proteomics have significantly contributed to understand the profile of viral proteins that affect respiratory pathways. Processes such as MS-based detection and RT-PCR were used to detect SARS-CoV-2 in the patients.
Moreover, during COVID-19 outbreak, proteomics has helped to reveal novel biomarkers and define point-of-care procedures.

The reagents segment to dominate throughout the forecast period-

Based on type, the reagents segment has accounted for more than three-fourths of the global proteomics market share in 2019 and will continue to lead by 2027. This is due to increased adoption of proteomics in diagnostic and medical industry. However, the instruments segment is expected to grow at the highest CAGR of 14.1% from 2020 to 2027, owing to unprecedented increase in R&D activities for the development of novel instruments that can be used for studying structure and functional roles of encoded proteins.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/1677

The drug discovery segment to lead the trial by 2027-

Based on application, the drug discovery segment contributed around three-fifths of the global proteomics market share in 2019, and will maintain its dominance during the forecast period. Introduction of safer, effective, and cost-effective drugs is expected to be the ultimate outcome of improvement of proteomics technology, which drives the growth of the segment. On the other hand, the disease diagnosis segment is expected to manifest the fastest CAGR of 12.6% during the forecast period.

North America to rule the roost throughout the forecast period-

Based on region, the market across North America accounted for nearly two-fifths of the global proteomics market share in 2019 and will maintain its leadership status by 2027. Proteomics research received a major boost in North America, due to the funding support by government organization. Therefore, increase in investments for R&D drives the market growth in this province. On the other hand, the Asia-Pacific region is expected to witness the highest growth rate, with a CAGR of 15.6 % from 2020 to 2027, owing to rise in demand for drug discovery and advances in the biotechnology sector.

The key players in the market-

Agilent Technologies Inc.
Danaher Corporation
LI-COR, Inc.
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
HORIBA, Ltd.
Bio-Rad Laboratories, Inc.
Bruker Corporation
General Electric (GE)
Waters Corporation

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Protein Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Protein Labeling Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

PEGylated Protein Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

C-Reactive Protein Testing Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Protein Engineering Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Placental Protein Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research